Winterthur, October 2018 – There's no doubt that medical technology numbers among the industries of the future. Demand for high-tech is no longer confined to Silicon Valley – especially when it is used to alleviate medical conditions or prolong life. Enormous growth potential is predicted for medical technology in the long term – and even today, the prospects are extremely promising.
This presents a great opportunity for Kistler to participate in the sector's growth – with the focus on the medical devices segment, i.e. products classified under 21 CFR 860 or European Directive 93/42/EEC. In this field, Kistler already supplies numerous customers with process monitoring systems that ensure functionality and quality in production for small medical devices such as inhalers, breathalyzers and insulin pens.